HYPERTET
Google image searchProduct monograph
Active ingredient
tetanus immunoglobulin (human), 250 UNIT/ML
DIN: 02520087
Dosage form(s): SOLUTION
Route(s) of administration: INTRAMUSCULAR
Description: PRE-FILLED 1ML SYRINGE
Schedule: Schedule D
Company: GRIFOLS THERAPEUTICS LLC
Date: 13-DEC-2021
ATC:
- J06 — IMMUNE SERA AND IMMUNOGLOBULINS (ATC, ATC/DDD, )
- J06B — IMMUNOGLOBULINS (ATC, ATC/DDD)
- J06BB — Specific immunoglobulins (ATC, ATC/DDD)
- J06BB02 — TETANUS IMMUNOGLOBULIN (ATC/DDD)
Reference brand drug: Hypertet
Pharmaceutical standard: MFR
